Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

Overview

About this study

Evaluate the safety and efficacy of the GORE® CARDIOFORM ASD Occluder in the percutaneous closure of ostium secundum atrial septal defects (ASDs)

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Appropriate ASD anatomy.
  • Note: Additional Inclusion Criteria may apply.

Exclusion Criteria:

  • Absence of concurrent cardiac conditions that could elevate morbidity/mortality beyond what is common for ASD.
  • Note: Additional Exclusion Criteria may apply.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Donald Hagler, M.D.

Closed for enrollment

Contact information:

Cheryl Wasson R.N.

(507)255-0876

Wasson.Cheryl@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20317443

Mayo Clinic Footer